ONO PHARMA USA is the US subsidiary of ONO PHARMACEUTICAL CO, LTD., an R&D-oriented pharmaceutical company founded in 1717, with headquarters in Osaka, Japan. For over 300 years, ONO has been committed to delivering novel medicines to patients with high unmet medical need. Our passion has led to first-in-class therapies including the world’s first chemically synthesized prostaglandins as well as nivolumab, the world’s first anti-PD-1 antibody. These drugs have changed the treatment paradigm and outlook for millions of people globally. Today, ONO has a growing pipeline of innovative therapeutics across four focus areas: oncology, immunology, neurology, and specialty medicine. ONO is committed to Challenging the Unknown, relentlessly pursuing research that will bring safe and effective solutions to more patients around the world. For information on our community guidelines, visit: http://bit.ly/43MdR0S
View Top Employees from ONO PHARMA USAWebsite | https://us.ono-pharma.com/ |
Employees | 117 (61 on RocketReach) |
Address | 1 Main Street Suite 1050, Cambridge, Massachusetts 02142, US |
Industry | Pharmaceutical Manufacturing |
Keywords | Pharmaceutical R&D, Cancer Treatment, Specialty Medicine |
Looking for a particular ONO PHARMA USA employee's phone or email?
Sarala Gudiwada is the Vice President, Drug Safety and Pharmacovigilance of ONO PHARMA USA.
61 people are employed at ONO PHARMA USA.
ONO PHARMA USA is based in Cambridge, Massachusetts.